about
Utilization of translational bioinformatics to identify novel biomarkers of bortezomib resistance in multiple myelomaPrognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure.Twitter Use in the Hematopoietic Cell Transplantation Community.Randomized clinical trial of the effect of supplemental opioids in procedural sedation with propofol on serum catecholamines.Prognostic Factors for Mortality among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation.Social Media and Hematopoietic Cell Transplantation: a Review of Online Resources and CommunitiesEffect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationImplementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology settingEarly diagnosis of intravascular large B-cell lymphoma: clues from routine blood smear morphologic findingsPatient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing TimesPatient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpointsMyeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyComparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeImpact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell TransplantationHematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current eraOutcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
P50
Q28544663-3C10150A-11CB-45F9-A164-DC911B2D650AQ39205101-D89A346B-F378-4CB9-BB34-9584F381B413Q47553073-0927F290-A3D2-4DB3-8210-28D84B60BEB6Q48005739-91317CDC-6629-4832-9B7C-FD2038C14052Q49709281-EA6AF617-6BB3-4A36-952B-BD1C4D71B8CBQ57462107-E34B61E5-FAEE-430A-90AE-199A35BC06F5Q58093525-0D0B77D0-460E-42B6-A4A9-28001D32BCB7Q64228869-539D1AF1-D8ED-45BE-B6CE-94141C8DB5BEQ87424438-AEFA3AF7-47D7-449A-AB0F-77AA830B8F89Q88810045-C18F1169-7ADD-44E0-9573-E35B052DBF21Q90208712-73EE7E24-EFE5-49D3-BA06-D2F9ECA7B7CEQ90465658-1FCBC7BD-C814-4D70-ABBE-877F0F660B50Q90816913-93108E62-9F04-405E-A1B0-18FAC8A23235Q91993552-6AE8F1AA-6EBA-4321-AEAB-57B9294843BFQ92094177-726B134E-5A59-4CE3-A4EC-7225C06475D5Q92760016-9F59C51D-EE8D-4FA0-9A5D-C5C63D5C40AC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sagar Patel
@en
Sagar Patel
@nl
type
label
Sagar Patel
@en
Sagar Patel
@nl
prefLabel
Sagar Patel
@en
Sagar Patel
@nl
P31
P496
0000-0001-9949-3615